# FDA Inspection 1261008 - Amgen Inc. - February 04, 2025

Source: https://www.keypedia.com/records/fda_inspections/amgen-inc/0f04db46-af09-4d46-8bf3-64fc432276c2
Source feed: FDA_Inspections

> FDA Inspection 1261008 for Amgen Inc. on February 04, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261008
- Company Name: Amgen Inc.
- Inspection Date: 2025-02-04
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1261008 - 2025-02-04](https://www.keypedia.com/records/fda_inspections/amgen-inc/fdbb8fb6-e5cc-459f-87af-26e4805d9d0b)
- [FDA Inspection 1228575 - 2024-01-17](https://www.keypedia.com/records/fda_inspections/amgen-inc/ef8f2368-9cc4-49d9-bb05-3c92b44b9d62)

Company: https://www.keypedia.com/companies/amgen-inc/f15d2d1c-3482-417a-83de-0efa632c4095

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c